Latest Overactive Bladder News
Men with nocturia have a 1.4-fold greater risk of death than men without nocturia, after adjustment for age and major comorbidities.
Lowering nocturnal urine production and enabling patients to void consistently at capacity may ease nocturia in men with low bladder capacity.
For men with nocturnal polyuria, the rate of urine production dropped off as the night progressed.
Increased facility use of mesh augmentation impacts risk of repeat prolapse repair surgery
Correlates of receiving prescription include female sex, specific physician specialty, geographic region
Desmopressin orally disintegrating tablets resulted in declines in nocturnal voids in men and women with nocturnal polyuria and mild daytime voiding dysfunction.
In a study, 28% of all incident in-hospital falls were associated with nighttime visits to the toilet.
In a study, nocturnal polyuria was present in 30% of women with overactive bladder.
Taking 2 or more drugs for hypertension is associated with a significantly higher number of nocturnal voids and higher nocturnal polyuria index, study finds.
Phase 4 trial showed that mirabegron significantly decreased incontinence episodes and micturitions compared with placebo among patients aged 65 years and older.
A study of commercially insured patients showed Asians and Hispanics were less likely than whites to undergo advanced overactive bladder treatments.
Study suggests male OAB could be associated with abnormalities in metabolic pathways of fatty acids and bile acids.
Even modestly elevated fasting plasma glucose levels and HbA1c is associated with increased odds of overactive bladder.
The ratio of visceral fat volume to total abdominal fat volume is an independent risk factor for overactive bladder, study finds.
German study revealed a 13% higher risk of falls among patients with vs without nocturia.
Renal and Urology News Articles
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)